The Experts below are selected from a list of 1938 Experts worldwide ranked by ideXlab platform

Tracy L. Simpson - One of the best experts on this subject based on the ideXlab platform.

  • association of participation in a Mindfulness Programme with bowel symptoms gastrointestinal symptom specific anxiety and quality of life
    Alimentary Pharmacology & Therapeutics, 2011
    Co-Authors: David J. Kearney, K. Mcdermott, M. Martinez, Tracy L. Simpson
    Abstract:

    Aliment Pharmacol Ther 2011; 34: 363–373 Summary Background  Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. Aim  To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life. Methods  This is a prospective study of 93 participants in MBSR. We applied measures of Rome III IBS status, bowel symptoms (IBS-Severity Scoring System, IBS-SSS), IBS-Quality of Life (IBS-QOL), GI-specific anxiety (Visceral Sensitivity Index, VSI), Mindfulness (Five Facet Mindfulness Questionnaire-FFMQ), and functional status (SF-8) at baseline and 2 and 6 months after enrolment. Results  At 2 months, participation in MBSR was associated with small nonsignificant changes in IBS-SSS, IBS-QOL and VSI: d = −0.25, d = 0.08, d = −0.16, respectively. At 6 months, there was no significant change in IBS-SSS (d = −0.36); whereas for IBS-QOL and VSI there were significant improvements (IBS-QOL: d = 0.33, P = 0.044; VSI: d = −0.40, P = 0.014). For patients meeting Rome III IBS criteria (n = 43), changes in IBS-SSS, IBS-QOL and VSI were not statistically significant, but there was a significant correlation between the change in VSI and the change in FFMQ across the three time periods (r = 0.33). Conclusions  Participation in MBSR is associated with improvement IBS-related quality of life and GI-specific anxiety. Randomised controlled trials are warranted to further assess the role of MBSR for IBS symptomatology.

  • Association of participation in a Mindfulness Programme with bowel symptoms, gastrointestinal symptom‐specific anxiety and quality of life
    Alimentary Pharmacology & Therapeutics, 2011
    Co-Authors: David J. Kearney, K. Mcdermott, M. Martinez, Tracy L. Simpson
    Abstract:

    Aliment Pharmacol Ther 2011; 34: 363–373 Summary Background  Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. Aim  To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life. Methods  This is a prospective study of 93 participants in MBSR. We applied measures of Rome III IBS status, bowel symptoms (IBS-Severity Scoring System, IBS-SSS), IBS-Quality of Life (IBS-QOL), GI-specific anxiety (Visceral Sensitivity Index, VSI), Mindfulness (Five Facet Mindfulness Questionnaire-FFMQ), and functional status (SF-8) at baseline and 2 and 6 months after enrolment. Results  At 2 months, participation in MBSR was associated with small nonsignificant changes in IBS-SSS, IBS-QOL and VSI: d = −0.25, d = 0.08, d = −0.16, respectively. At 6 months, there was no significant change in IBS-SSS (d = −0.36); whereas for IBS-QOL and VSI there were significant improvements (IBS-QOL: d = 0.33, P = 0.044; VSI: d = −0.40, P = 0.014). For patients meeting Rome III IBS criteria (n = 43), changes in IBS-SSS, IBS-QOL and VSI were not statistically significant, but there was a significant correlation between the change in VSI and the change in FFMQ across the three time periods (r = 0.33). Conclusions  Participation in MBSR is associated with improvement IBS-related quality of life and GI-specific anxiety. Randomised controlled trials are warranted to further assess the role of MBSR for IBS symptomatology.

David J. Kearney - One of the best experts on this subject based on the ideXlab platform.

  • association of participation in a Mindfulness Programme with bowel symptoms gastrointestinal symptom specific anxiety and quality of life
    Alimentary Pharmacology & Therapeutics, 2011
    Co-Authors: David J. Kearney, K. Mcdermott, M. Martinez, Tracy L. Simpson
    Abstract:

    Aliment Pharmacol Ther 2011; 34: 363–373 Summary Background  Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. Aim  To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life. Methods  This is a prospective study of 93 participants in MBSR. We applied measures of Rome III IBS status, bowel symptoms (IBS-Severity Scoring System, IBS-SSS), IBS-Quality of Life (IBS-QOL), GI-specific anxiety (Visceral Sensitivity Index, VSI), Mindfulness (Five Facet Mindfulness Questionnaire-FFMQ), and functional status (SF-8) at baseline and 2 and 6 months after enrolment. Results  At 2 months, participation in MBSR was associated with small nonsignificant changes in IBS-SSS, IBS-QOL and VSI: d = −0.25, d = 0.08, d = −0.16, respectively. At 6 months, there was no significant change in IBS-SSS (d = −0.36); whereas for IBS-QOL and VSI there were significant improvements (IBS-QOL: d = 0.33, P = 0.044; VSI: d = −0.40, P = 0.014). For patients meeting Rome III IBS criteria (n = 43), changes in IBS-SSS, IBS-QOL and VSI were not statistically significant, but there was a significant correlation between the change in VSI and the change in FFMQ across the three time periods (r = 0.33). Conclusions  Participation in MBSR is associated with improvement IBS-related quality of life and GI-specific anxiety. Randomised controlled trials are warranted to further assess the role of MBSR for IBS symptomatology.

  • Association of participation in a Mindfulness Programme with bowel symptoms, gastrointestinal symptom‐specific anxiety and quality of life
    Alimentary Pharmacology & Therapeutics, 2011
    Co-Authors: David J. Kearney, K. Mcdermott, M. Martinez, Tracy L. Simpson
    Abstract:

    Aliment Pharmacol Ther 2011; 34: 363–373 Summary Background  Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. Aim  To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life. Methods  This is a prospective study of 93 participants in MBSR. We applied measures of Rome III IBS status, bowel symptoms (IBS-Severity Scoring System, IBS-SSS), IBS-Quality of Life (IBS-QOL), GI-specific anxiety (Visceral Sensitivity Index, VSI), Mindfulness (Five Facet Mindfulness Questionnaire-FFMQ), and functional status (SF-8) at baseline and 2 and 6 months after enrolment. Results  At 2 months, participation in MBSR was associated with small nonsignificant changes in IBS-SSS, IBS-QOL and VSI: d = −0.25, d = 0.08, d = −0.16, respectively. At 6 months, there was no significant change in IBS-SSS (d = −0.36); whereas for IBS-QOL and VSI there were significant improvements (IBS-QOL: d = 0.33, P = 0.044; VSI: d = −0.40, P = 0.014). For patients meeting Rome III IBS criteria (n = 43), changes in IBS-SSS, IBS-QOL and VSI were not statistically significant, but there was a significant correlation between the change in VSI and the change in FFMQ across the three time periods (r = 0.33). Conclusions  Participation in MBSR is associated with improvement IBS-related quality of life and GI-specific anxiety. Randomised controlled trials are warranted to further assess the role of MBSR for IBS symptomatology.

M. Martinez - One of the best experts on this subject based on the ideXlab platform.

  • association of participation in a Mindfulness Programme with bowel symptoms gastrointestinal symptom specific anxiety and quality of life
    Alimentary Pharmacology & Therapeutics, 2011
    Co-Authors: David J. Kearney, K. Mcdermott, M. Martinez, Tracy L. Simpson
    Abstract:

    Aliment Pharmacol Ther 2011; 34: 363–373 Summary Background  Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. Aim  To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life. Methods  This is a prospective study of 93 participants in MBSR. We applied measures of Rome III IBS status, bowel symptoms (IBS-Severity Scoring System, IBS-SSS), IBS-Quality of Life (IBS-QOL), GI-specific anxiety (Visceral Sensitivity Index, VSI), Mindfulness (Five Facet Mindfulness Questionnaire-FFMQ), and functional status (SF-8) at baseline and 2 and 6 months after enrolment. Results  At 2 months, participation in MBSR was associated with small nonsignificant changes in IBS-SSS, IBS-QOL and VSI: d = −0.25, d = 0.08, d = −0.16, respectively. At 6 months, there was no significant change in IBS-SSS (d = −0.36); whereas for IBS-QOL and VSI there were significant improvements (IBS-QOL: d = 0.33, P = 0.044; VSI: d = −0.40, P = 0.014). For patients meeting Rome III IBS criteria (n = 43), changes in IBS-SSS, IBS-QOL and VSI were not statistically significant, but there was a significant correlation between the change in VSI and the change in FFMQ across the three time periods (r = 0.33). Conclusions  Participation in MBSR is associated with improvement IBS-related quality of life and GI-specific anxiety. Randomised controlled trials are warranted to further assess the role of MBSR for IBS symptomatology.

  • Association of participation in a Mindfulness Programme with bowel symptoms, gastrointestinal symptom‐specific anxiety and quality of life
    Alimentary Pharmacology & Therapeutics, 2011
    Co-Authors: David J. Kearney, K. Mcdermott, M. Martinez, Tracy L. Simpson
    Abstract:

    Aliment Pharmacol Ther 2011; 34: 363–373 Summary Background  Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. Aim  To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life. Methods  This is a prospective study of 93 participants in MBSR. We applied measures of Rome III IBS status, bowel symptoms (IBS-Severity Scoring System, IBS-SSS), IBS-Quality of Life (IBS-QOL), GI-specific anxiety (Visceral Sensitivity Index, VSI), Mindfulness (Five Facet Mindfulness Questionnaire-FFMQ), and functional status (SF-8) at baseline and 2 and 6 months after enrolment. Results  At 2 months, participation in MBSR was associated with small nonsignificant changes in IBS-SSS, IBS-QOL and VSI: d = −0.25, d = 0.08, d = −0.16, respectively. At 6 months, there was no significant change in IBS-SSS (d = −0.36); whereas for IBS-QOL and VSI there were significant improvements (IBS-QOL: d = 0.33, P = 0.044; VSI: d = −0.40, P = 0.014). For patients meeting Rome III IBS criteria (n = 43), changes in IBS-SSS, IBS-QOL and VSI were not statistically significant, but there was a significant correlation between the change in VSI and the change in FFMQ across the three time periods (r = 0.33). Conclusions  Participation in MBSR is associated with improvement IBS-related quality of life and GI-specific anxiety. Randomised controlled trials are warranted to further assess the role of MBSR for IBS symptomatology.

K. Mcdermott - One of the best experts on this subject based on the ideXlab platform.

  • association of participation in a Mindfulness Programme with bowel symptoms gastrointestinal symptom specific anxiety and quality of life
    Alimentary Pharmacology & Therapeutics, 2011
    Co-Authors: David J. Kearney, K. Mcdermott, M. Martinez, Tracy L. Simpson
    Abstract:

    Aliment Pharmacol Ther 2011; 34: 363–373 Summary Background  Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. Aim  To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life. Methods  This is a prospective study of 93 participants in MBSR. We applied measures of Rome III IBS status, bowel symptoms (IBS-Severity Scoring System, IBS-SSS), IBS-Quality of Life (IBS-QOL), GI-specific anxiety (Visceral Sensitivity Index, VSI), Mindfulness (Five Facet Mindfulness Questionnaire-FFMQ), and functional status (SF-8) at baseline and 2 and 6 months after enrolment. Results  At 2 months, participation in MBSR was associated with small nonsignificant changes in IBS-SSS, IBS-QOL and VSI: d = −0.25, d = 0.08, d = −0.16, respectively. At 6 months, there was no significant change in IBS-SSS (d = −0.36); whereas for IBS-QOL and VSI there were significant improvements (IBS-QOL: d = 0.33, P = 0.044; VSI: d = −0.40, P = 0.014). For patients meeting Rome III IBS criteria (n = 43), changes in IBS-SSS, IBS-QOL and VSI were not statistically significant, but there was a significant correlation between the change in VSI and the change in FFMQ across the three time periods (r = 0.33). Conclusions  Participation in MBSR is associated with improvement IBS-related quality of life and GI-specific anxiety. Randomised controlled trials are warranted to further assess the role of MBSR for IBS symptomatology.

  • Association of participation in a Mindfulness Programme with bowel symptoms, gastrointestinal symptom‐specific anxiety and quality of life
    Alimentary Pharmacology & Therapeutics, 2011
    Co-Authors: David J. Kearney, K. Mcdermott, M. Martinez, Tracy L. Simpson
    Abstract:

    Aliment Pharmacol Ther 2011; 34: 363–373 Summary Background  Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. Aim  To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life. Methods  This is a prospective study of 93 participants in MBSR. We applied measures of Rome III IBS status, bowel symptoms (IBS-Severity Scoring System, IBS-SSS), IBS-Quality of Life (IBS-QOL), GI-specific anxiety (Visceral Sensitivity Index, VSI), Mindfulness (Five Facet Mindfulness Questionnaire-FFMQ), and functional status (SF-8) at baseline and 2 and 6 months after enrolment. Results  At 2 months, participation in MBSR was associated with small nonsignificant changes in IBS-SSS, IBS-QOL and VSI: d = −0.25, d = 0.08, d = −0.16, respectively. At 6 months, there was no significant change in IBS-SSS (d = −0.36); whereas for IBS-QOL and VSI there were significant improvements (IBS-QOL: d = 0.33, P = 0.044; VSI: d = −0.40, P = 0.014). For patients meeting Rome III IBS criteria (n = 43), changes in IBS-SSS, IBS-QOL and VSI were not statistically significant, but there was a significant correlation between the change in VSI and the change in FFMQ across the three time periods (r = 0.33). Conclusions  Participation in MBSR is associated with improvement IBS-related quality of life and GI-specific anxiety. Randomised controlled trials are warranted to further assess the role of MBSR for IBS symptomatology.

Peter Kuppens - One of the best experts on this subject based on the ideXlab platform.

  • processes of change in a school based Mindfulness Programme cognitive reactivity and self coldness as mediators
    Cognition & Emotion, 2018
    Co-Authors: Katleen Van Der Gucht, Filip Raes, Keisuke Takano, Peter Kuppens
    Abstract:

    ABSTRACTThe underlying mechanisms of the effectiveness of Mindfulness-based interventions for emotional well-being remain poorly understood. Here, we examined the potential mediating effects of cognitive reactivity and self-compassion on symptoms of depression, anxiety and stress using data from an earlier randomised controlled school trial. A moderated time-lagged mediation model based on multilevel modelling was used to analyse the data. The findings showed that post-treatment changes in cognitive reactivity and self-coldness, an aspect of self-compassion, mediated subsequent changes in symptoms of depression, anxiety and stress. These results suggest that cognitive reactivity and self-coldness may be considered as transdiagnostic mechanisms of change of a Mindfulness-based intervention Programme for youth.